RxDoctor Payments Data

Joseph Hsu, MD

Orthopaedic Trauma · Charlotte, NCNPI 1083698427

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.7%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Stryker accounts for 68.4% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $212,025, 4.4 times the $48,233 reported in 2019.

$483,446in general payments, 2019–2025

Across 380 payments — averaging $1272.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$331K
  • Smith+Nephew$111K
  • Globus Medical$21K
  • Medical Device Business Services, Inc.$6K
  • Integra Lifesciences Corporation$4K
  • Peerless Surgical Inc.$4K
  • plus $8K from 15 others

What the payments were for

  • Royalty or licence$129,13527%
  • Consulting fees$196,87541%
  • Speaking & faculty fees$91,43119%
  • Travel & lodging$49,89310%
  • Food & beverage$13,6263%
  • Education$2,4851%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in North Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$51,889
Medicare patients
87
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin14$300

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →